MAGE-1 and MAGE-3 or -6 expression in neuroblastoma-related pediatric solid tumors

International Journal of Cancer

Volumn 69, Issue 5, 1996, Pages 375-380

  Ishida, Hiroyuki ^a   Matsumura, Takafumi ^a   Salgaller, Michael L ^b   Ohmizono, Yoshikazu ^a   Kadono, Yosuke ^a   Sawada, Tadashi ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAGE ANTIGEN; MELANOMA ANTIGEN; TUMOR REJECTION ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CHILDHOOD CANCER; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROBLASTOMA; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE;

ANTIGENS, NEOPLASM; CHILD, PRESCHOOL; CYTOTOXICITY TESTS, IMMUNOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFANT; NEOPLASM PROTEINS; NEUROBLASTOMA; RHABDOMYOSARCOMA; TUMOR CELLS, CULTURED; WILMS TUMOR;

EID: 0029806332     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19961021)69:5<375::AID-IJC4>3.0.CO;2-2     Document Type: Article

References (18)

1. BOON, T., Tumor antigens recognized by cytolytic T lymphocytes: present perspectives for specific immunotherapy. Int. J. Cancer, 54, 177-180 (1993).
2. BRASSEUR, F., MARCHAND, M., VANWIJCK, R., HERIN, M., LETHE, B., CHOMEZ, P. and BOON, T., Human gene MAGE-1, which codes for a tumor-rejection antigen, is expressed by some breast tumors. Int. J. Cancer, 52, 839-841 (1992).
3. BRASSEUR, F. and 29 OTHERS, Expression of MAGE genes in primary and metastatic cutaneous melanoma. Int. J. Cancer, 63, 375-380 (1995).
4. BROWNING, M.J., KRAUSA, P., ROMAN, A., BICKNELL, D.C., BODMER, J.G. and BOOMER, W.F., Tissue typing the HLA-A locus from genomic DNA by sequence-specific PCR: comparison of HLA genotype and surface expression on colorectal tumor cell lines. Proc. nat. Acad. Sci. (Wash.), 90, 2842-2845 (1993).
5. CHOMCZYNSKI, P. and SACCHI, N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159 (1987).
6. ENGELHARD, V.H., Structure of peptides associated with class 1 and class 2 MHC molecules. Ann. Rev. Immunol., 12, 181-207 (1994).
7. GAUGLER, B., VAN DEN EYNDE, B., VAN DER BRUGGEN, P., ROMERO, P., GAFORIO, J.J., DE OLAEN, E., LETHE, B., BRASSEUR, F. and BOON, T., Human gene MAGE-3 codes for an antigen recognized on melanoma by autologous cytolytic T lymphocytes. J. exp. Med., 179, 921-930 (1994).
8. HELLSTRÖM, K.E. and HELLSTRÖM, I., Immunity to neuroblastomas and melanomas. Ann. Rev. Med., 23, 19-38 (1972).
9. MARCHAND, M., BRASSEUR, F., VAN DER BRUGGEN, P., COULIE, P. and BOON, T., Perspectives for immunization of HLA-A1 patients carrying a malignant melanoma expressing gene MAGE-1. Dermatology, 186, 278-280 (1993).
10. PATARD, J.J., BRASSEUR, F., GIL-DIEZ, S., RADVANYI, F., MARCHAND, M., FRANCOIS, P., ABI-AAD, A., VAN CANGH, P., ABBOU, C.C., CHOPIN, D. and BOON, T., Expression of MAGE genes in transitional-cell carcinomas of the urinary bladder. Int. J. Cancer, 64, 61-64 (1995).
11. RIMOLDI, D., ROMERO, P. and CARREL, S., The human melanoma antigen-encoding gene, MAGE-1, is expressed by other tumor cells of neuroectodermal origin such as glioblastomas and neuroblastomas. Int. J. Cancer, 54, 527-528 (1993).
12. RUSSO, V., TRAVERSARI, T., VERRECCHIA, A., MOTTOLESE, M., NATALI, P.G. and BORDINGNON, C., Expression of the MAGE gene family in primary and metastatic human breast cancer: implications for tumor antigen-specific immunotherapy. Int. J. Cancer, 64, 216-221 (1995).
13. SALGALLER, M.L., WEBER, J.S., KOENING, S., YANNELLI, J.R. and ROSENBERG, S.A., Generation of specific anti-melanoma reactivity by stimulation of human tumor-infiltrating lymphocytes with MAGE-1 synthetic peptide. Cancer Immunol. Immunother., 39, 105-116 (1994).
14. SAMBROOK, J., FRITSCH, E.F. and MANIATIS, T., Molecular cloning, pp 9.16-9.19, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY (1989).
15. SHICHIJO, S., HAYASHI, A., TAKAMORI, S., TSUNOSUE, R., HOSHINO, T., SAKATA, M., KURAMOTO, T., OIZUMI, K. and ITOH, K., Detection of MAGE-4 protein in lung cancers. Int. J. Cancer, 64, 158-165 (1995).
16. TOH, Y., YAMANA, H., SHICHIJO, S., FUJITA, H., TOU, U., SAKAGUCHI, M., KAKEGAWA, T. and ITOH, K., Expression of MAGE-1 gene by esophageal carcinomas. Jap. J. Cancer, 86, 714-717 (1995).
17. VAN DER BRUGGEN, P., TRAVERSARI, C., CHOMEZ, P., LURQUIN, C., DE PLAEN, E., VAN DEN EYNDE, B., KNUTH, A. and BOON, T., A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (Wash.), 254, 1643-1647 (1991).
18. WEYNANTS, P., LETHE, B., BRASSEUR, F., MARCHAND, M. and BOON, T., Expression of MAGE genes by non-small-cell lung carcinomas. Int. J. Cancer, 56, 826-829 (1994).